| scholarly article | Q13442814 |
| P2093 | author name string | Frank M Szaba | |
| Lawrence W Kummer | |||
| Stephen T Smiley | |||
| Isis K Mullarky | |||
| Michelle A Parent | |||
| Lindsey B Wilhelm | |||
| P2860 | cites work | Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages | Q37078811 |
| Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens | Q37868873 | ||
| Cell-mediated protection against pulmonary Yersinia pestis infection | Q39393406 | ||
| Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. | Q39573935 | ||
| Plague Immunization. I. Past and Present Trends | Q39940120 | ||
| Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice | Q41185362 | ||
| Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague | Q41461188 | ||
| The SCID/Beige mouse as a model to investigate protection against Yersinia pestis | Q41483548 | ||
| Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine | Q41485426 | ||
| Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice | Q41485594 | ||
| Multidrug resistance in Yersinia pestis mediated by a transferable plasmid | Q41487671 | ||
| In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice | Q41507498 | ||
| Plague Bacillus: Survival within Host Phagocytes | Q41524761 | ||
| The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. | Q41569171 | ||
| Immunity in plague; a critical consideration of some recent studies. | Q41575211 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| Yersinia pestis--etiologic agent of plague | Q29619320 | ||
| Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils | Q33225645 | ||
| T cell responses to bacterial infection | Q33711392 | ||
| Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense | Q33901607 | ||
| Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus | Q33943840 | ||
| TNF-alpha and IL-12: a balancing act in macrophage functioning | Q34184417 | ||
| Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity | Q34201893 | ||
| Yersinia pestis (plague) vaccines | Q34324211 | ||
| The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance | Q34334393 | ||
| Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells | Q34388169 | ||
| Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice | Q34440132 | ||
| Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. | Q34520336 | ||
| Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen) | Q35159314 | ||
| Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens | Q35648247 | ||
| Interferon-gamma activation of polymorphonuclear neutrophil function | Q35750735 | ||
| Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon | Q35783031 | ||
| Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans | Q36174591 | ||
| Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity | Q36227843 | ||
| Fibrin-mediated protection against infection-stimulated immunopathology | Q36370606 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Yersinia pestis | Q153875 |
| P304 | page(s) | 3381-3386 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection | |
| P478 | volume | 74 |
| Q91760327 | A Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against Yersinia Infection in Adult and Infant Mice |
| Q92090453 | A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice |
| Q36898462 | A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague |
| Q33816162 | A parenteral DNA vaccine protects against pneumonic plague |
| Q33557963 | Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis |
| Q35418294 | Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges |
| Q37066749 | An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague |
| Q34163944 | An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague |
| Q41441607 | Antibodies and cytokines independently protect against pneumonic plague. |
| Q34045080 | Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa. |
| Q33310431 | Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells |
| Q33500145 | CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells |
| Q36845217 | Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. |
| Q36984064 | Cell-mediated defense against Yersinia pestis infection |
| Q35810279 | Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. |
| Q34189701 | Contrasted patterns of selection on MHC-linked microsatellites in natural populations of the Malagasy plague reservoir |
| Q36628038 | Current challenges in the development of vaccines for pneumonic plague |
| Q37355852 | D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague |
| Q37450884 | Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague |
| Q35113336 | Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion |
| Q33798021 | Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague |
| Q34633478 | HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model |
| Q64092755 | Human Macrophages Clear the Biovar Microtus Strain of More Efficiently Than Murine Macrophages |
| Q37287818 | Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. |
| Q34786724 | IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection |
| Q33584403 | Immune defense against pneumonic plague |
| Q40512106 | Immunology of Yersinia pestis Infection |
| Q41384167 | Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant |
| Q90169705 | Induction of protective anti-plague immune responses by self-adjuvanting bionanoparticles derived from the engineered Yersinia pestis |
| Q36288336 | Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor |
| Q37415511 | Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation |
| Q36594020 | Interaction between Yersinia pestis and the host immune system |
| Q36911486 | Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection |
| Q34819434 | Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge |
| Q34298699 | LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague |
| Q36960814 | Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine |
| Q34645327 | Mathematical relationship between cytokine concentrations and pathogen levels during infection |
| Q41447516 | Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis |
| Q41400297 | Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model |
| Q33786763 | Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice |
| Q35836140 | Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. |
| Q33502706 | O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies |
| Q27343051 | Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague |
| Q36372952 | Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague |
| Q56706594 | Plague |
| Q36099515 | Protection against pneumonic plague following oral immunization with a non-replicating vaccine |
| Q37688618 | Rational considerations about development of live attenuated Yersinia pestis vaccines |
| Q36373952 | Recombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection |
| Q92644859 | Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague |
| Q34380204 | TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. |
| Q41432452 | Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. |
| Q33496136 | The role of relA and spoT in Yersinia pestis KIM5 pathogenicity |
| Q36845312 | Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages |
| Q41451306 | Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection |
| Q34290878 | Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques |
| Q41437577 | Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages |
| Q33675781 | Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague |
| Q35073117 | YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected]. |
| Q64906371 | γ-herpesvirus latency attenuates Mycobacterium tuberculosis infection in mice. |
Search more.